<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1248458</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2023.1248458</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Deciphering the binding mechanism of an anti-cancer phytochemical plumbagin with calf thymus DNA using biophysical and <italic>in silico</italic> techniques</article-title>
<alt-title alt-title-type="left-running-head">Rahaman et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1248458">10.3389/fchem.2023.1248458</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rahaman</surname>
<given-names>Abdul</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/884887/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anjum</surname>
<given-names>Farah</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1492612/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kumari</surname>
<given-names>Aknita</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1863825/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shafie</surname>
<given-names>Alaa</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1482028/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alee</surname>
<given-names>Mahafooj</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2141253/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Badr</surname>
<given-names>Omnia</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1867231/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khan</surname>
<given-names>Shaheer Hasan</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1934587/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ashour</surname>
<given-names>Amal Adnan</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hazazi</surname>
<given-names>Ali</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arif</surname>
<given-names>Sultan</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zeng</surname>
<given-names>Xin-An</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1231677/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Guangdong Key Laboratory of Food Intelligent Manufacturing</institution>, <institution>Foshan University</institution>, <addr-line>Foshan</addr-line>, <addr-line>Guangdong</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>School of Food Science and Engineering</institution>, <institution>Foshan University</institution>, <addr-line>Foshan</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Clinical Laboratory Sciences</institution>, <institution>College of Applied Medical Sciences</institution>, <institution>Taif University</institution>, <addr-line>Taif</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>School of Food Science and Engineering</institution>, <institution>South China University of Technology</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Genetics and Genetic Engineering</institution>, <institution>Faculty of Agriculture</institution>, <institution>Benha University</institution>, <addr-line>Qalyubia</addr-line>, <country>Egypt</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Enzymology and Nanotechnology Laboratory</institution>, <institution>Interdisciplinary Biotechnology Unit</institution>, <institution>Aligarh Muslim University</institution>, <addr-line>Aligarh</addr-line>, <country>India</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Oral and Maxillofacial Surgery and Diagnostic Sciences</institution>, <institution>Faculty of Dentistry</institution>, <institution>Taif University</institution>, <addr-line>Taif</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Department of Pathology and Laboratory Medicine</institution>, <institution>Security Forces Hospital Program</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff9">
<sup>9</sup>
<institution>Department of Plastic Surgery and Burn Unit</institution>, <institution>Security Forces Hospital</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff10">
<sup>10</sup>
<institution>Overseas Expertise Introduction Centre for Discipline Innovation of Food Nutrition and Human Health (111 Centre)</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/387261/overview">Khurshid Ahmad</ext-link>, Yeungnam University, Republic of Korea</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/599797/overview">Mohammad Aslam</ext-link>, Fujian Agriculture and Forestry University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1383695/overview">Anshul Tiwari</ext-link>, Vanderbilt University, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1975239/overview">Bhupinder Kumar</ext-link>, Hemwati Nandan Bahuguna Garhwal University, India</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Xin-An Zeng, <email>xazeng@scut.edu.cn</email>; Omnia Badr, <email>omnia.badr@fagr.bu.edu.eg</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1248458</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>08</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Rahaman, Anjum, Kumari, Shafie, Alee, Badr, Khan, Ashour, Hazazi, Arif and Zeng.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Rahaman, Anjum, Kumari, Shafie, Alee, Badr, Khan, Ashour, Hazazi, Arif and Zeng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Plumbagin (PLM), a plant derivative, is well known for a wide range of therapeutic effects in humans including anti-cancer, anti-inflammatory, anti-oxidant, and anti-microbial. Cytotoxic and genotoxic potential of this phytochemical has been studied which demands further insight. DNA being a major target for several drugs was taken to study against PLM to understand its effects on the cellular system. UV-Vis spectroscopy has indicated the binding of PLM to ctDNA and dye displacement assays have confirmed the formation of PLM-ctDNA complex. The insignificant changes in circular dichroism spectra suggested that PLM is not affecting the structural makeup of the ctDNA, hence the binding could be peripheral and not intercalating. Further, the relative viscosity and minimal change in melting temperature upon the complex formation supported this finding and confirmed the groove binding of PLM. Molecular docking analysis and simulation studies also show PLM as a minor groove binder to DNA and provide details on the interaction dynamics of PLM-DNA complex. Docking followed by a 100&#xa0;ns simulation reveals the negative Gibbs free energy change (&#x2206;G &#x3d; &#x2212;6.6&#xa0;kcal&#xa0;mol<sup>&#x2212;1</sup>), and the formation of a stable complex. The PLM- DNA complex with stable dynamics was further supported by different parameters including RMSD, RMSF, SASA, Rg, and the energy profile of interaction. This study provides an insight into the cytotoxic and genotoxic mechanism of PLM which can be a crucial step forward to exploit its therapeutic potential against several diseases including cancer.</p>
</abstract>
<kwd-group>
<kwd>cancer</kwd>
<kwd>Plumbagin</kwd>
<kwd>groove binder</kwd>
<kwd>biophysical</kwd>
<kwd>circular dichroism</kwd>
<kwd>molecular simulation</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Medicinal and Pharmaceutical Chemistry</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Plumbagin (PLM) [5- hydroxy-2-methyl-1,4-naphthoquinone] is an established anti-cancer agent, the effects of which have been studied in breast cancer, ovarian cancer, lung cancer, acute promyelocytic leukemia, and prostate cancer (<xref ref-type="bibr" rid="B2">Aziz et al., 2008</xref>; <xref ref-type="bibr" rid="B17">Manu et al., 2011</xref>; <xref ref-type="bibr" rid="B35">Subramaniya et al., 2011</xref>; <xref ref-type="bibr" rid="B11">Lai et al., 2012</xref>; <xref ref-type="bibr" rid="B33">Sinha et al., 2013</xref>; <xref ref-type="bibr" rid="B19">Niu et al., 2015</xref>; <xref ref-type="bibr" rid="B16">Liu et al., 2017</xref>). PLM is a plant derivative of Plumbago zeylanica and belongs to one of the largest and most diverse groups of plant metabolites (<xref ref-type="bibr" rid="B3">Chen et al., 2009</xref>). In cancer cells, PLM has been critical in inhibiting growth, invasion, and metastasis; induction of apoptosis; and anti-angiogenesis. PLM causes the suppression of major signalling molecules which are essential for cancer cell development including AKT/mTOR, nuclear factor-kappa B, and signal transducer and activator of transcription 3 (<xref ref-type="bibr" rid="B2">Aziz et al., 2008</xref>; <xref ref-type="bibr" rid="B17">Manu et al., 2011</xref>; <xref ref-type="bibr" rid="B33">Sinha et al., 2013</xref>).</p>
<p>Deoxyribonucleic acid (DNA) is the prime site for the storage of genetic information in humans. If this information gets compromised at any level, the results can be dangerous and deadly, because DNA has its role in multiple life processes including replication, transcription, gene expression, etc. (<xref ref-type="bibr" rid="B14">Li et al., 2012</xref>). DNA-small molecule interaction has gained much interest in the fields of biological and chemical sciences which demands to acquire an in-depth understanding of its mechanism (<xref ref-type="bibr" rid="B13">Lefstin and Yamamoto, 1998</xref>; <xref ref-type="bibr" rid="B22">Rajendiran et al., 2008</xref>; <xref ref-type="bibr" rid="B24">Rehman et al., 2015</xref>). These types of interactions provide further insights into the structural properties of DNA with the mode of binding and mechanism of the small molecules influencing DNA functioning and their consequences.</p>
<p>DNA can bind to small molecules or drugs through covalent or non-covalent interactions, the dominant ones being the non-covalent bonds, which are further classified into intercalations, electrostatic interactions, and groove binding interactions (<xref ref-type="bibr" rid="B26">Sarkar et al., 2008</xref>). The complexity of these interactions always demands an in-depth investigation to fully exploit their potential (<xref ref-type="bibr" rid="B4">Froehlich et al., 2011</xref>). Hence, there is always a scope for improvement to better understand the significance and impact of the binding of a particular compound with DNA.</p>
<p>In the present study, calf thymus DNA (ctDNA) was interacted with PLM. Different spectroscopic, thermal stability and hydrodynamics experiments were performed to study the interaction, helix melting, and viscosity of DNA in the presence of PLM. Molecular docking and simulation studies were performed to establish the mode of binding and understand the dynamics of PLM-DNA complex. All the results provided important insight regarding PLM-ctDNA complex formation and the mechanism of PLM action while interacting with DNA. While providing an important step towards studying the PLM mechanism inside the cell, this work will further require a rigorous clinical research to establish the discussed finding and impact.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Materials</title>
<p>PLM, ctDNA, ethidium bromide (EB), acridine orange (AO), and Hoechst 33,258 were procured from Sigma Aldrich (USA). Sodium phosphate buffer (20&#xa0;mM; pH 7.4) was used as the solvent for most of the experiments.</p>
</sec>
<sec id="s2-2">
<title>2.2 UV-vis spectroscopic analysis</title>
<p>The absorption spectra were recorded using a UV-1800 Shimadzu spectrophotometer (Japan) in the range 220&#x2013;320&#xa0;nm for PLM and PLM-ctDNA complex. The baseline was corrected with the buffer (sodium phosphate, pH 7.4; 25&#xb0;C) and the concentration of PLM was fixed at 20&#xa0;&#xb5;M, while the concentration of ctDNA varied from 2 to 20&#xa0;&#xb5;M.</p>
</sec>
<sec id="s2-3">
<title>2.3 Dye displacement measurements</title>
<p>The fluorescence spectra of the samples were obtained using a Shimadzu RF-5301pc spectrofluorometer (Japan). In the EB displacement assay, the concentration of EB (20&#xa0;&#xb5;M) was kept fixed with ctDNA (40&#xa0;&#xb5;M), while the concentration of PLM was varied between 5&#x2013;50&#xa0;&#xb5;M. The emission spectra of the EB-ctDNA complex were recorded between 520&#x2013;670&#xa0;nm, keeping excitation fixed at 360&#xa0;nm. In the AO displacement assay, the emission spectra of the AO-ctDNA complex were recorded within the range of 490&#x2013;630&#xa0;nm, with a fixed excitation wavelength at 480&#xa0;nm. The slits for both excitation and emission spectra were set at 10&#xa0;nm. The concentration of DNA was fixed at 40&#xa0;&#xb5;M while the concentration of PLM was varied between 5&#x2013;50&#xa0;&#xb5;M for titration. Similarly, the DNA-Hoechst 33,258 complex spectra were obtained after excitation at 343&#xa0;nm, and the emission spectra in this experiment were recorded between 350&#x2013;600&#xa0;nm. The Stern&#x2013;Volmer for all three displacement experiments was plotted based on fluorescence quenching to predict the binding site of PLM while forming the complex.</p>
</sec>
<sec id="s2-4">
<title>2.4 Circular dichroism (CD) measurements</title>
<p>CD spectra of ctDNA and PLM-ctDNA complex were measured using a JASCO-J-813 spectropolarimeter with a Peltier-type temperature controller. The spectra were recorded at 298&#xa0;K from 220 to 300&#xa0;nm, using a quartz cell with a path length of 0.1&#xa0;cm. The molar ratios of the PLM-ctDNA complex were 1:0, 1:1, and 1:2. The CD spectra were expressed in CD (mdeg) units after subtraction of corresponding blanks.</p>
</sec>
<sec id="s2-5">
<title>2.5 Viscosity measurements</title>
<p>To further understand the binding mechanism between PLM and ctDNA, viscosity measurements were performed. The experiment was carried out at a constant temperature of 25&#xb0;C &#xb1; 0.5&#xb0;C using a UBBELOHDE viscometer. The concentration of ctDNA was kept constant at 150&#xa0;&#xb5;M, while different concentrations of PLM were used. The flow time was measured using a digital stopwatch, and the mean of three replicates was recorded for each sample. The relative specific viscosity (&#x03B7;/&#x03B7;O)1/3 values were determined and plotted against the ratio of [ligand]/[DNA] concentrations. Here, &#x03B7;O and &#x03B7; represent the viscosity contributions of DNA in the absence and presence of PLM, respectively.</p>
</sec>
<sec id="s2-6">
<title>2.6 Helix melting studies</title>
<p>UV-spectrophotometer (UV-1800 Shimadzu, Japan) using 1 &#xd7; 1&#xa0;cm quartz cuvettes, coupled with a thermostat bath was utilized to conduct the helix melting studies. The analysis of ctDNA double-stranded structure was done in the presence and absence of PLM at 260&#xa0;nm, with temperature variation. All melts were performed using quartz cells with a 1&#xa0;cm path length. The temperature was varied from 35&#xb0;C to 90&#xb0;C, and the relative absorbance was plotted against the temperature. The DNA melting temperature (Tm) was calculated as the midpoint of the transition observed in the plot.</p>
</sec>
<sec id="s2-7">
<title>2.7 Molecular docking analysis</title>
<p>AutoDock Vina was used to study the interaction between PLM and ctDNA. The ctDNA molecule used for docking studies was the dodecamer d (CGCGAATTCGCG)2 (PDB ID: 1BNA), and its 3D structure was obtained from the Protein Data Bank. Prior to docking, MGL-Tools-1.5.6 was used to add polar hydrogen atoms and Gasteiger charges to the ctDNA molecule. A grid box of dimensions 58 &#xd7; 72 &#xd7; 112&#xa0;&#xc5; was set up, with the center of the grid located at X &#x3d; 14.759, Y &#x3d; 20.984, and Z &#x3d; 8.812, and a spacing of 1&#xa0;&#xc5; was used to cover the entire DNA molecule. The structure of PLM, obtained from PubChem (CID: 10,205) in sdf format, was converted to pdb format using Chimera-1.10.2 and optimized using Avogadro software. The docking calculations were performed using AutoDock vina with an exhaustiveness of 100, and the Broyden-Fletcher-Goldfarb-Shanno algorithm was used. The PyMOL software package was used to analyze the output and present the data in 3D form. LigPlot&#x2b; (version v.2.2.8) was used to plot the 2D representation of the interacting residues with the ligand molecule (<xref ref-type="bibr" rid="B37">Wallace et al., 1995</xref>).</p>
</sec>
<sec id="s2-8">
<title>2.8 Molecular dynamics simulation</title>
<p>The study of the complex formed by PLM with DNA was carried out using molecular dynamics simulations (MDS) with GROMACS 2018.1 (<xref ref-type="bibr" rid="B20">P&#xe1;ll et al., 2015</xref>). The amber99sb- ILDN force field was used to simulate the system, and the structures were solvated in a triclinic box using the TIP3P water model. To neutralize the structures, 22 sodium ions were added. The ligand topology was generated using the antechamber program in AmberTools19, which is a software suite for carrying out MDS. The energy minimization step was performed to remove any weak Van der Waals contacts and optimize the structures of both the DNA and PLM-DNA complex. This was done using the steepest descent algorithm with 5,000 steps. After the energy minimization step, both systems were equilibrated for NVT using the V- rescale thermostat for 100&#xa0;ps at a temperature of 300&#xa0;K. The NPT ensemble was then used to further equilibrate the systems for 1,000&#xa0;ps at a pressure of 1.0&#xa0;bar using the Parrinello-Rahman barostat. The Particle-Mesh Ewald method is a widely used algorithm in MDS for computing long-range electrostatic interactions. It combines real space and reciprocal space calculations to calculate the electrostatic interactions between charged particles. The Van der Waals interactions were set at 1.2&#xa0;nm, which is a typical value used in many MDS. The Linear Constraint Solver (LINCS) algorithm is used to constrain covalent bond lengths and bond angles during MDS. This algorithm is used to maintain the geometry of the molecule during the simulation and prevent unrealistic bond lengths or angles from occurring. The LINCS algorithm is especially useful in simulations that involve stiff molecules such as proteins or nucleic acids. The heavy atom-H bonds were also constrained using this algorithm to prevent unrealistic movements of the atoms during the simulation. The gmxrms, gmxrmsf, gmxgyrate, gmxhbond, gmx sasa utilities were used to calculate root mean squared deviation (RMSD), root mean squared fluctuation (RMSF), radius of gyration (Rg), hydrogen bonds, and solvent accessible surface area (SASA), respectively. The MM-PBSA calculations were performed after simulation to calculate the binding energy of ligands and receptors (<xref ref-type="bibr" rid="B10">Kumari et al., 2014</xref>).</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 UV&#x2013;vis spectroscopy</title>
<p>UV-Vis spectroscopy is a prevalent technique for investigating the interaction of small molecules, drugs, and biological molecules such as proteins or DNA (<xref ref-type="bibr" rid="B32">Shi et al., 2015</xref>; <xref ref-type="bibr" rid="B1">Ahmad and Ahmad, 2018</xref>). In this study, UV-Vis spectroscopy was employed to analyze the absorbance spectra of the PLM-DNA complex. The absorbance of PLM alone was observed at 270&#xa0;nm as its characteristic peak, but when DNA was added, there was a significant increase in absorption with a shift in the position of the peak <bold>(</bold>
<xref ref-type="fig" rid="F1">Figure 1</xref>
<bold>)</bold>. The decreased absorbance (hypochromicity) and red-shift in the maxima suggest an intercalative mode of binding between DNA and small molecules, according to previous studies (<xref ref-type="bibr" rid="B21">Rahban et al., 2010</xref>). However, our findings, combined with the existing literature, led us to suggest that PLM may interact with ctDNA through a non-intercalative mode (<xref ref-type="bibr" rid="B39">Wang et al., 2002</xref>; <xref ref-type="bibr" rid="B31">Shahabadi and Hadidi, 2012</xref>). While this technique does not provide detailed mechanistic insights into the possible binding mode of PLM-ctDNA, it served as a basis for further experiments to establish these results.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>UV spectra of PLM with and without ctDNA.</p>
</caption>
<graphic xlink:href="fchem-11-1248458-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Competitive displacement assay</title>
<p>The common fluorophores were used to study the binding mode of PLM-ctDNA interaction. EB is a strong intercalative agent; its fluorescence intensity increases in the presence of DNA (<xref ref-type="bibr" rid="B34">Song et al., 2000</xref>). Researchers have found out that the enhanced emission intensity of EB-DNA complex can be quenched by the addition of another molecule if this molecule also binds through the same mode as EB. While binding to the similar position the molecule can displace the EB and this results in the decreased fluorescence intensity of the EB&#x2013;DNA complex (<xref ref-type="bibr" rid="B42">Wu et al., 2011</xref>; <xref ref-type="bibr" rid="B15">Li et al., 2014</xref>). Acridine orange dye (AO), behaves the same way as, i.e., intercalation as in EB (<xref ref-type="bibr" rid="B29">Sayed et al., 2016</xref>). The result suggests that PLM does not have a significant effect on the binding of EB and AO to ctDNA. Therefore, the lack of change in fluorescence upon the addition of PLM suggests that PLM does not interfere with the intercalation of EB and AO into ctDNA (<xref ref-type="fig" rid="F2">Figure 2A</xref>). This led us to the conclusion that PLM was not able to replace EB or AO while forming the complex with ctDNA, suggesting that PLM does not bind through intercalative binding mode. Hoechst 33,258 is a known minor groove binder that was used to further elucidate the binding of PLM with ctDNA (<xref ref-type="bibr" rid="B9">Kakkar and Garg, 2002</xref>; <xref ref-type="bibr" rid="B5">Guan et al., 2006</xref>). There was a significant decrease in the fluorescence spectra of Hoechst-ctDNA complex upon the addition of PLM to the said complex, suggesting PLM binds to DNA through the same mode as Hoechst 33,258 dye (<xref ref-type="fig" rid="F2">Figure 2B</xref>). That is, PLM could replace Hoechst from the grooves of DNA thus decreasing the fluorescence. This quenching of the Hoechst-ctDNA complex upon the addition of PLM provides additional evidence to confirm non-intercalative binding mode of PLM to ctDNA (<xref ref-type="fig" rid="F2">Figure 2C</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Dye displacement assays with varying concentrations of PLM; <bold>(A)</bold> Ethidium bromide, <bold>(B)</bold> Acridine orange, <bold>(C)</bold> Hoechst, <bold>(D)</bold> Combined Stern&#x2013;Volmer for PLM-ctDNA binding constant.</p>
</caption>
<graphic xlink:href="fchem-11-1248458-g002.tif"/>
</fig>
<p>The KSV values of all three displaced dyes (EB, AO and Hoechst) bound to ctDNA by PLM were calculated, using the Stern&#x2013;Volmer plot (<xref ref-type="bibr" rid="B12">Lakowicz, 2006</xref>) as shown in <xref ref-type="fig" rid="F2">Figure 2D</xref>. KSV values of EB, AO and Hoechst were 0.21 &#xd7; 10<sup>4</sup> (M<sup>&#x2212;1</sup>), 4.25 &#xd7; 10<sup>4</sup> (M<sup>&#x2212;1</sup>) and 12.6 &#xd7; 10<sup>4</sup> (M<sup>&#x2212;1</sup>). The results clearly indicate that the KSV value for Hoechst-ctDNA complex was significantly higher than that for EB/AO-ctDNA complex, indicating PLM binding at the position of Hoechst in ctDNA. This suggests that PLM may bind to the DNA in the minor groove, possibly after displacing Hoechst.</p>
</sec>
<sec id="s3-3">
<title>3.3 Circular dichroism study</title>
<p>CD is a highly informative and sensitive method that helps to comprehend changes in the secondary structure of biological molecules, such as DNA and proteins, when they interact with small molecules (<xref ref-type="bibr" rid="B6">Holm et al., 2010</xref>). These modifications depend on the non-covalent interactions between DNA and small molecules and can lead to changes in the intrinsic CD spectral behavior (<xref ref-type="bibr" rid="B43">Zhang et al., 2011</xref>). The CD spectrum of ctDNA showed a positive peak at approximately 276&#xa0;nm, which is attributed to base stacking, and a negative peak at around 245&#xa0;nm, which is indicative of right-handed double helical DNA helicity (<xref ref-type="bibr" rid="B15">Li et al., 2014</xref>), (<xref ref-type="fig" rid="F3">Figure 3</xref>). The intensity and position of these peaks can be significantly altered by the interaction of DNA with small molecules (<xref ref-type="bibr" rid="B7">Ivanov et al., 1973</xref>; <xref ref-type="bibr" rid="B36">Uma Maheswari and Palaniandavar, 2004</xref>). Studies have indicated that when DNA binds with small molecules through intercalation, it causes significant alterations in base stacking and helicity, while the electrostatic interactions and groove binding have no significant impact on these characteristics of DNA structure (<xref ref-type="bibr" rid="B18">Mergny et al., 1992</xref>; <xref ref-type="bibr" rid="B8">Jain et al., 2003</xref>). From <xref ref-type="fig" rid="F3">Figure 3</xref>, it is clear that the addition of PLM to ctDNA did not cause any significant perturbations in the CD spectra. These results further suggest that PLM acts as a groove binder for DNA rather than an intercalator.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Effect of PLM (varying concentrations; 1:1 and 1:2) on CD spectra of ctDNA.</p>
</caption>
<graphic xlink:href="fchem-11-1248458-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Viscosity measurement</title>
<p>A classical intercalative case of ligand binding increases the length of DNA because of the stacking of small molecules between the base pairs; hence, increasing the viscosity of the DNA (<xref ref-type="bibr" rid="B27">Satyanarayana et al., 1992</xref>; <xref ref-type="bibr" rid="B28">1993</xref>). Whereas, when the small molecules bind to DNA through groove binding or electrostatic mode, no significant change in viscosity is found (<xref ref-type="bibr" rid="B30">Shahabadi et al., 2011</xref>; <xref ref-type="bibr" rid="B23">Raman et al., 2012</xref>). To further confirm the non-intercalative binding mode of PLM to ctDNA, the relative specific viscosity (&#x03B7;/&#x03B7;O)1/3versus [ligand]/[DNA] ratio was plotted. The results showed an insignificant change in the viscosity upon the continued addition of PLM to ctDNA (<xref ref-type="fig" rid="F4">Figure 4</xref>), which is consistent with groove binding rather than intercalation. These results further concrete the groove binding mode and rule out the possibility of intercalation.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effect of PLM binding on the relative viscosity of ctDNA.</p>
</caption>
<graphic xlink:href="fchem-11-1248458-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Helix melting study</title>
<p>The melting of double-stranded DNA (dsDNA) is referred to as the separation of two strands of the DNA, and the temperature at which half of the DNA is in double-stranded and the other half is in single-stranded form is called the melting temperature (Tm) (<xref ref-type="bibr" rid="B40">Wijeratne et al., 2011</xref>). The absorbance intensity of DNA shows a sharp increase as the two strands separate because the extinction coefficient of dsDNA bases at 260&#xa0;nm is much less as compared to DNA in single-stranded form (<xref ref-type="bibr" rid="B25">Roy et al., 2009</xref>; <xref ref-type="bibr" rid="B38">Wang et al., 2012</xref>). The intercalative binding mode results in a sharp increase in Tm (4&#xb0;C&#x2013;8&#xa0;&#xb0;C), whereas groove-binding interaction shows no effect or less effects on Tm (<xref ref-type="bibr" rid="B41">Wilson et al., 1994</xref>). In this study, from the DNA melting profiles, the estimated Tm were found to be 66 and 70 for the unbound ctDNA and PLM-bound DNA, respectively (<xref ref-type="fig" rid="F5">Figure 5</xref>). The insignificant increase in Tm upon PLM binding strengthens the earlier experimental claims that PLM binds to ctDNA through groove-binding mode.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Helix melting profile of ctDNA in absence and presence of PLM.</p>
</caption>
<graphic xlink:href="fchem-11-1248458-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 Molecular docking analysis</title>
<p>Molecular modelling and docking studies were executed for obtaining details about the PLM&#x2013;DNA interaction; this further validate the <italic>in vitro</italic> experimental results. The 2D and 3D representations of conformations were selected, among the 10 binding modes, based on the lowest binding free energy (&#x2212;6.6&#xa0;kcal&#xa0;mol<sup>&#x2212;1</sup>). The binding constant value for the PLM-DNA complex was calculated to be 6.92 &#xd7; 10<sup>4</sup>&#xa0;M<sup>&#x2212;1</sup>. The molecular docking analysis revealed that PLM formed four hydrogen bonds with the nitrogenous bases along the helix and Van der Waal interactions were observed for minor groove binding (<xref ref-type="fig" rid="F6">Figure 6</xref>). Thus, the molecular docking analysis supports the results obtained from the <italic>in vitro</italic> studies, indicating that PLM binds to the groove of DNA. The further validation of the stability of the complex was analyzed by molecular dynamics simulation.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Molecular docking analysis of PLM-DNA complex showing <bold>(A)</bold> 3D image of PLM-DNA complex, <bold>(B)</bold> 2D image of PLM showing interaction with DNA, and <bold>(C)</bold> LigPlot of PLM-DNA complex showing hydrogen bonding and Van Der Waal interactions.</p>
</caption>
<graphic xlink:href="fchem-11-1248458-g006.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>3.7 Molecular simulation analysis</title>
<sec id="s3-7-1">
<title>3.7.1 RMSD</title>
<p>MDS was performed to evaluate the stability of DNA and its complex with PLM over 100&#xa0;ns. The RMSD values of both systems were calculated relative to their initial structures. It was observed that the RMSD value of DNA reached equilibrium after about 20&#xa0;ns with a value of around 0.35&#xa0;nm. The average RMSD of DNA was 0.321&#xa0;nm and PLM-DNA was 0.253&#xa0;nm, showing a difference of 0.068&#xa0;nm in the RMSD due to the formation of complex. The lowered average RMSD value of the PLM-DNA complex indicates its stability in an aqueous environment. The RMSD of the ligand molecule was also calculated and found to be less than 0.05&#xa0;nm throughout the simulation period, further confirming the stability of the complex. The visual analysis of the trajectories also supports the stability of both the DNA and DNA-PLM complex systems (<xref ref-type="fig" rid="F7">Figure 7A</xref>). These results suggest that the PLM-DNA complex is stable and can withstand fluctuations in the aqueous environment.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>MDS analysis elaborating the interaction dynamics and the stability of the PLM-DNA complex. <bold>(A)</bold> RMSD plot, <bold>(B)</bold> RMSF plot, <bold>(C)</bold> Rg plot, <bold>(D)</bold> SASA plot, <bold>(E)</bold> Potential energy, <bold>(F)</bold> Total energy.</p>
</caption>
<graphic xlink:href="fchem-11-1248458-g007.tif"/>
</fig>
</sec>
<sec id="s3-7-2">
<title>3.7.2 RMSF</title>
<p>The RMSF values of the DNA and its complex with PLM was calculated as a result of averaging all the snapshots during the 100&#xa0;ns simulation implying the determination of the dynamic behaviour of the residues in DNA. These values provide insight into structural flexibility and fluctuations of different regions. If fluctuations are more, it means that the residues are unstable, otherwise residues are said to be stable. The RMSFs of C&#x3b1; atoms of the DNA and DNA- PLM complex was shown in <xref ref-type="fig" rid="F7">Figure 7B</xref>. Most of the residues in the DNA and its complex were observed to have values below 0.2&#xa0;nm except for the terminal residues and the general shape of the fluctuation curve for both complexes was similar. However, the terminal residues also show decreased RMSF values when complexed with PLM conferring to stabilizing the fluctuation of residues as a result of interaction with the ligand molecule.</p>
</sec>
<sec id="s3-7-3">
<title>3.7.3 Compactness and SASA</title>
<p>Rg is known to be a measure of stability in a system during MDS. Biomolecular structures that are compact tend to have less variation in Rg values, while those that are expanded tend to have higher Rg values. The Rg values of both the DNA and DNA-PLM complex were plotted against time in <xref ref-type="fig" rid="F7">Figure 7C</xref>. The results showed that the binding of PLM to the DNA molecule slightly increased the compactness of the structure compared to the free DNA molecule, as evidenced by a slight decrement in the Rg values of the DNA-PLM complex. The Rg values remained relatively constant over the entire simulation time of 100&#xa0;ns, indicating that the systems were in equilibrium.</p>
<p>The SASA variations of both the systems, DNA and PLM-DNA complex, were shown in <xref ref-type="fig" rid="F7">Figure 7D</xref>. As observed for Rg, the SASA values for both the systems were also found to be approximately much alike which further describes the stability of DNA and DNA-PLM complex.</p>
</sec>
<sec id="s3-7-4">
<title>3.7.4 Energy analysis</title>
<p>The physicochemical parameters of the systems were also analyzed to confirm their stability. The potential energy and total energy of both the DNA and DNA-PLM complex systems were examined, as depicted in <xref ref-type="fig" rid="F7">Figures 7E, F</xref>. The smooth curves observed for both parameters indicate that the systems reached equilibrium and remained stable throughout the 100&#xa0;ns simulation period.</p>
</sec>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>PLM is a widely used anti-cancer phytocompound which has several other effects on cellular system. The mechanism of its effects and possible consequences needs to be understood for better utilization of its potential and to minimize its adverse outcomes. This study shows that PLM interacts with DNA to form a stable complex targeting the minor groove of this double-stranded molecule. This complex formation may result in a range of structural changes to the DNA leading towards the genotoxicity of the drug which can also be exploited in terms of targeted delivery. Here, the insights into the PLM-DNA binding mechanism calls for the further studies related to PLM mode of action related to other biomolecules and to further explore its therapeutic potential, while it gets administered into the human body.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>Conceptualization, AR, OB, and X-AZ; formal analysis, AK, MA, FA, and AS; methodology, AK, SK, and MA; original draft preparation, AR, SK, and MA; review and editing, OB, AA, AH, SA, and X-AZ. All authors contributed to the article and approved the final version.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was supported by the S&#x26;T Project of Yangjiang (SDZX2020012), Guangdong Provincial Key Laboratory of Intelligent Food Manufacturing (2022B1212010015), the National Natural Science Foundation of China (32172348, 31972205), the Key Science and Technology projects of Xinjiang Uygur Autonomous Regions (2022A02002-4), and the S&#x26;T Project of China-Singapore International Joint Research Institute (201-A022005).</p>
</sec>
<ack>
<p>The researchers would like to acknowledge Deanship of Scientific Research, Taif University for funding this work.</p>
</ack>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Deciphering the mechanism of interaction of edifenphos with calf thymus DNA</article-title>. <source>Spectrochim. Acta A Mol. Biomol. Spectrosc.</source> <volume>188</volume>, <fpage>244</fpage>&#x2013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2017.07.014</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aziz</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Dreckschmidt</surname>
<given-names>N. E.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>A. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer</article-title>. <source>Cancer Res.</source> <volume>68</volume>, <fpage>9024</fpage>&#x2013;<lpage>9032</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.can-08-2494</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Plumbagin, isolated from Plumbago zeylanica, induces cell death through apoptosis in human pancreatic cancer cells</article-title>. <source>Pancreatology</source> <volume>9</volume>, <fpage>797</fpage>&#x2013;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1159/000210028</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Froehlich</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mandeville</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Weinert</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Kreplak</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tajmir-Riahi</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Bundling and aggregation of DNA by cationic dendrimers</article-title>. <source>Biomacromolecules</source> <volume>12</volume>, <fpage>511</fpage>&#x2013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1021/bm1013102</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Determination of nucleic acids based on the fluorescence quenching of Hoechst 33258 at pH 4.5</article-title>. <source>Anal. Chim. acta</source> <volume>570</volume>, <fpage>21</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.aca.2006.03.106</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holm</surname>
<given-names>A. I. S.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>S. B.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Vacuum-ultraviolet circular dichroism spectroscopy of DNA: a valuable tool to elucidate topology and electronic coupling in DNA</article-title>. <source>Phys. Chem. Chem. Phys.</source> <volume>12</volume>, <fpage>9581</fpage>&#x2013;<lpage>9596</lpage>. <pub-id pub-id-type="doi">10.1039/c003446k</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanov</surname>
<given-names>V. I.</given-names>
</name>
<name>
<surname>Minchenkova</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Schyolkina</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Poletayev</surname>
<given-names>A. I.</given-names>
</name>
</person-group> (<year>1973</year>). <article-title>Different conformations of double-stranded nucleic acid in solution as revealed by circular dichroism</article-title>. <source>Biopolymers</source> <volume>12</volume>, <fpage>89</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1002/bip.1973.360120109</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jain</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Polak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hud</surname>
<given-names>N. V.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Controlling nucleic acid secondary structure by intercalation: effects of DNA strand length on coralyne-driven duplex disproportionation</article-title>. <source>Nucleic Acids Res.</source> <volume>31</volume>, <fpage>4608</fpage>&#x2013;<lpage>4615</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg648</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kakkar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Suruchi</surname>
</name>
</person-group> (<year>2002</year>). <article-title>Theoretical study of tautomeric structures and fluorescence spectra of Hoechst 33258</article-title>. <source>J. Mol. Struct. THEOCHEM</source> <volume>579</volume>, <fpage>109</fpage>&#x2013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-1280(01)00721-7</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lynn</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations</article-title>. <source>J. Chem. Inf. Model</source> <volume>54</volume>, <fpage>1951</fpage>&#x2013;<lpage>1962</lpage>. <pub-id pub-id-type="doi">10.1021/ci500020m</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2</article-title>. <source>Br. J. Pharmacol.</source> <volume>165</volume>, <fpage>1084</fpage>&#x2013;<lpage>1096</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01532.x</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Lakowicz</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>2006</year>). <source>Principles of fluorescence spectroscopy</source>. <publisher-loc>Berlin, Germany</publisher-loc>: <publisher-name>Springer</publisher-name>.</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lefstin</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K. R.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Allosteric effects of DNA on transcriptional regulators</article-title>. <source>Nature</source> <volume>392</volume>, <fpage>885</fpage>&#x2013;<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1038/31860</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B. Q.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Molecular spectroscopy evidence of berberine binding to DNA: Comparative binding and thermodynamic profile of intercalation</article-title>. <source>Biomacromolecules</source> <volume>13</volume>, <fpage>873</fpage>&#x2013;<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1021/bm2017959</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Determination of metolcarb binding to DNA by spectroscopic and chemometrics methods with the use of acridine orange as a probe</article-title>. <source>Sensors Actuators B Chem.</source> <volume>191</volume>, <fpage>464</fpage>&#x2013;<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.snb.2013.10.022</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Anticancer properties and pharmaceutical applications of plumbagin: A review</article-title>. <source>Am. J. Chin. Med.</source> <volume>45</volume>, <fpage>423</fpage>&#x2013;<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1142/s0192415x17500264</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manu</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Shanmugam</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Rajendran</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ramachandran</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hay</surname>
<given-names>H. S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4</article-title>. <source>Mol. Cancer</source> <volume>10</volume>, <fpage>107</fpage>. <pub-id pub-id-type="doi">10.1186/1476-4598-10-107</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mergny</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Duval-Valentin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Perrouault</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Faucon</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Roug&#xe9;e</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>1992</year>). <article-title>Triple helix-specific ligands</article-title>. <source>Science</source> <volume>256</volume>, <fpage>1681</fpage>&#x2013;<lpage>1684</lpage>. <pub-id pub-id-type="doi">10.1126/science.256.5064.1681</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Plumbagin inhibits growth of gliomas <italic>in vivo</italic> via suppression of FOXM1 expression</article-title>. <source>J. Pharmacol. Sci.</source> <volume>128</volume>, <fpage>131</fpage>&#x2013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphs.2015.06.005</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>P&#xe1;ll</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abraham</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kutzner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lindahl</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). &#x201c;<article-title>Tackling exascale software challenges in molecular dynamics simulations with GROMACS</article-title>,&#x201d; in <conf-name>Solving Software Challenges for Exascale: International Conference on Exascale Applications and Software, EASC 2014</conf-name>, <conf-loc>Stockholm, Sweden</conf-loc>, <conf-date>April 2014</conf-date> (<publisher-name>Springer</publisher-name>), <fpage>3</fpage>&#x2013;<lpage>27</lpage>.</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahban</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Divsalar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saboury</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Golestani</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Nanotoxicity and spectroscopy studies of silver nanoparticle: Calf thymus DNA and K562 as targets</article-title>. <source>J. Phys. Chem. C</source> <volume>114</volume>, <fpage>5798</fpage>&#x2013;<lpage>5803</lpage>. <pub-id pub-id-type="doi">10.1021/jp910656g</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajendiran</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Murali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Suresh</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Palaniandavar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Periasamy</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Akbarsha</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Non-covalent DNA binding and cytotoxicity of certain mixed-ligand ruthenium(II) complexes of 2,2&#x27;-dipyridylamine and diimines</article-title>. <source>Dalton Trans.</source>, <fpage>2157</fpage>&#x2013;<lpage>2170</lpage>. <pub-id pub-id-type="doi">10.1039/b715077f</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raman</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sobha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mitu</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Synthesis, structure elucidation, DNA interaction, biological evaluation, and molecular docking of an isatin-derived tyramine bidentate Schiff base and its metal complexes</article-title>. <source>Monatsh. f&#xfc;r Chemie-Chemical Mon.</source> <volume>143</volume>, <fpage>1019</fpage>&#x2013;<lpage>1030</lpage>. <pub-id pub-id-type="doi">10.1007/s00706-011-0699-8</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehman</surname>
<given-names>S. U.</given-names>
</name>
<name>
<surname>Sarwar</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Husain</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Ishqi</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Tabish</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Studying non-covalent drug-DNA interactions</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>576</volume>, <fpage>49</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2015.03.024</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhowmick</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Santhanagopal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ramakumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chakravarty</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Photo-induced double-strand DNA and site-specific protein cleavage activity of L-histidine (&#x3bc;-oxo) diiron (III) complexes of heterocyclic bases</article-title>. <source>Dalton Trans.</source>, <fpage>4671</fpage>&#x2013;<lpage>4682</lpage>. <pub-id pub-id-type="doi">10.1039/b901337g</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Basak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chattopadhyay</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Binding interaction of cationic phenazinium dyes with calf thymus DNA: A comparative study</article-title>. <source>J. Phys. Chem. B</source> <volume>112</volume>, <fpage>9243</fpage>&#x2013;<lpage>9249</lpage>. <pub-id pub-id-type="doi">10.1021/jp801659d</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satyanarayana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dabrowiak</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Chaires</surname>
<given-names>J. B.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Neither.DELTA.- nor.LAMBDA.-tris(phenanthroline)ruthenium(II) binds to DNA by classical intercalation</article-title>. <source>Biochemistry</source> <volume>31</volume>, <fpage>9319</fpage>&#x2013;<lpage>9324</lpage>. <pub-id pub-id-type="doi">10.1021/bi00154a001</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satyanarayana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dabrowiak</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Chaires</surname>
<given-names>J. B.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: Mode and specificity of binding</article-title>. <source>Biochemistry</source> <volume>32</volume>, <fpage>2573</fpage>&#x2013;<lpage>2584</lpage>. <pub-id pub-id-type="doi">10.1021/bi00061a015</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sayed</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Krishnamurthy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pal</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Unraveling multiple binding modes of acridine orange to DNA using a multispectroscopic approach</article-title>. <source>Phys. Chem. Chem. Phys.</source> <volume>18</volume>, <fpage>24642</fpage>&#x2013;<lpage>24653</lpage>. <pub-id pub-id-type="doi">10.1039/c6cp03716j</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahabadi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fatahi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mahdavi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nejad</surname>
<given-names>Z. K.</given-names>
</name>
<name>
<surname>Pourfoulad</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Multispectroscopic studies of the interaction of calf thymus DNA with the anti-viral drug, valacyclovir</article-title>. <source>Spectrochimica Acta Part A Mol. Biomol. Spectrosc.</source> <volume>83</volume>, <fpage>420</fpage>&#x2013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2011.08.056</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahabadi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hadidi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Spectroscopic studies on the interaction of calf thymus DNA with the drug levetiracetam</article-title>. <source>Spectrochim. Acta A Mol. Biomol. Spectrosc.</source> <volume>96</volume>, <fpage>278</fpage>&#x2013;<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2012.05.045</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y. Y.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Binding interaction between sorafenib and calf thymus DNA: Spectroscopic methodology, viscosity measurement and molecular docking</article-title>. <source>Spectrochim. Acta A Mol. Biomol. Spectrosc.</source> <volume>136</volume>, <fpage>443</fpage>&#x2013;<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2014.09.056</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pal</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Elkhanany</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mondal</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells <italic>in vivo</italic>
</article-title>. <source>Int. J. Cancer</source> <volume>132</volume>, <fpage>1201</fpage>&#x2013;<lpage>1212</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.27724</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Study on the fluorescence spectra and electrochemical behavior of ZnL2 and Morin with DNA</article-title>. <source>Spectrochim. Acta A Mol. Biomol. Spectrosc.</source> <volume>56a</volume>, <fpage>2491</fpage>&#x2013;<lpage>2497</lpage>. <pub-id pub-id-type="doi">10.1016/s1386-1425(00)00340-1</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramaniya</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sadullah</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Subhadara</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Halagowder</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2</article-title>. <source>PLoS One</source> <volume>6</volume>, <fpage>e18695</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0018695</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uma Maheswari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Palaniandavar</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>DNA binding and cleavage properties of certain tetrammine ruthenium(II) complexes of modified 1,10-phenanthrolines--effect of hydrogen-bonding on DNA-binding affinity</article-title>. <source>J. Inorg. Biochem.</source> <volume>98</volume>, <fpage>219</fpage>&#x2013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2003.09.003</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Laskowski</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Thornton</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Ligplot: A program to generate schematic diagrams of protein-ligand interactions</article-title>. <source>Protein Eng.</source> <volume>8</volume>, <fpage>127</fpage>&#x2013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1093/protein/8.2.127</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Specific binding of a dihydropyrimidinone derivative with DNA: Spectroscopic, calorimetric and modeling investigations</article-title>. <source>J. luminescence</source> <volume>132</volume>, <fpage>1656</fpage>&#x2013;<lpage>1662</lpage>. <pub-id pub-id-type="doi">10.1016/j.jlumin.2012.02.021</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>A spectroscopic study on the DNA binding behavior of the anticancer drug dacarbazine</article-title>. <source>Spectrosc. Lett.</source> <volume>35</volume>, <fpage>751</fpage>&#x2013;<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1081/sl-120016277</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wijeratne</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Kiang</surname>
<given-names>C.-H.</given-names>
</name>
</person-group> (<year>2011</year>). &#x201c;<article-title>Melting transitions of DNA-capped gold nanoparticle assemblies</article-title>,&#x201d; in <source>Reviews in plasmonics 2010</source> (<publisher-loc>Berlin, Germany</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>269</fpage>&#x2013;<lpage>282</lpage>.</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mizan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Taniuos</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>The interaction of intercalators and groove-binding agents with DNA triple-helical structures: The influence of ligand structure, DNA backbone modifications and sequence</article-title>. <source>J. Mol. Recognit.</source> <volume>7</volume>, <fpage>89</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1002/jmr.300070206</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>A schiff base ligand N-(2-hydroxylacetophenone)-3-oxapentane-1, 5-diamine and its nickel (II) complex: synthesis, crystal structure, antioxidation, and DNA-binding properties</article-title>. <source>Transit. Metal. Chem.</source> <volume>36</volume>, <fpage>847</fpage>&#x2013;<lpage>853</lpage>. <pub-id pub-id-type="doi">10.1007/s11243-011-9539-2</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Spectroscopic studies of the interaction between pirimicarb and calf thymus DNA</article-title>. <source>Spectrochimica Acta Part A Mol. Biomol. Spectrosc.</source> <volume>78</volume>, <fpage>687</fpage>&#x2013;<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2010.11.050</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>